Currently Browsing: Parexel

COVID-19Lessons Learned

A ‘Holy Grail Moment’ for Clinical Research

November 23, 2020

It was a familiar scenario: A rare disease area of oncology. A new drug candidate. A desire to assess efficacy as safely and quickly as possible, so that if successful, a new therapy could get approved and change lives. But this desire could have been tempered by reality: the trial was going to be challenging and slow…

COVID-19Lessons Learned

A Catalyst for Innovation, Urgency for Now, Momentum for the Future

October 19, 2020

For Dr. Sy Pretorius, Parexel’s Chief Medical & Scientific Officer, COVID-19 has been a catalyst. The pandemic has accelerated innovations that make it easier for patients to participate and for sponsors to conduct research. Parexel has seen increases in decentralized trials and remote monitoring, where study designs were adapted amidst the pandemic.